Immune to Cancer: The CRI Blog
-
The IO Clinical Trial Gap in the Black Patient Population: It’s Time to Sound the Alarm
In 2017, I was diagnosed with stage four triple-negative breast cancer (TNBC), one of the most aggressive… -
Breast Cancer Awareness Month: 2021 Immunotherapy Research Updates
This October for Breast Cancer Awareness Month, learn about new treatments, research discoveries, and our impact on…
-
Brenda’s Immunotherapy Story
Breast Cancer | Diagnosed 1986 It’s like the best gift I ever had. Brenda’s Story When Brenda Berchtold,… -
Dr. Sylvia Adams and Victor Ty Answer Questions on Breast Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit
Sylvia Adams, MD, and Victor Ty, BSN, RN, answer questions on immunotherapy for breast cancer from the…
-
Breast Cancer Awareness Month: 2020 Immunotherapy Research Updates
This October for Breast Cancer Awareness Month, we look at new treatments, new research, and how we’re…
-
AACR20 Day 1 Highlights: Breast Cancer, Lung Cancer, and the Microbiome
The first day of the 2020 AACR Annual Meeting shared latest data from immunotherapy clinical trials in…
-
Breast Cancer Awareness Month: 2019 Immunotherapy Research Update
For Breast Cancer Awareness Month, we round up the latest news and research from the people changing…
-
How Immunotherapy Is Making an Impact in Breast Cancer
We spoke with Rebecca A. Shatsky, MD, about the current treatment landscape for patients with breast cancer,…
-
Transforming Experience into Advocacy
Judy Perkins discusses her experience receiving immunotherapy for metastatic stage 4 breast cancer and insights she shared…